Australia's TGA changes policy on annual device charges
This article was originally published in SRA
Australia's Therapeutic Goods Administration is doing away with the current option under which it allows medical device companies to pay in instalments the annual charges for including their products on to the Australian Register of Therapeutic Goods1.
You may also be interested in...
A new draft guideline explains how sponsors of subsequent-entry orally inhaled drug products can comply with the Canadian requirement for demonstrating equivalence to the reference product.
While good clinical practice inspectors in the UK and the US collaborate on matters of common interest, they say that mutual recognition is simply not possible.
Whoever takes over as chair of the Medicines and Healthcare products Regulatory Agency will play a key role in its plans to deliver a program of “ambitious business change.”